Actionable Stock Market Trading Newswire. Built for Traders, by Traders.
All news is property of their respective owners.

Home Newsfeeds Barclays Maintains Overweight on Amazon.com. Price adjusts to $195

Barclays Maintains Overweight on Amazon.com. Price adjusts to $195

Barclays analyst Ross Sandler maintains Amazon.com (NASDAQ:AMZN) with a Overweight. Price adjusts to $195

byBenzinga Newsdesk

July 15, 2022

1 minute read

Barclays analyst Ross Sandler maintains Amazon.com (NASDAQ:AMZN) with a Overweight. Price adjusts to $195

Recent Report Shows That Rep. Virginia Foxx Sold Up to $100K Worth of Kellogg Stock

By Benzinga Insights

April 5, 11:05 AM

Virginia Foxx, a Representative from North Carolina, reported a sale of Kellogg (NYSE:K) stock on April 4, 2023.…

Ford Downgraded – Analyst Says Its Gen 2 EV Lags Compared To General Motors

By Nabaparna Bhattacharya

January 17, 3:25 PM

UBS analyst downgrades Ford to Neutral, amid concerns over Gen 2 EV lag and labor headwinds.

EMA Talks Ongoing With Moderna About Application For Spikevax BA.4/BA.5 Adapted Bivalent Covid-19 Vaccine, Start Of Review Expected End Of Sept

By Benzinga Newsdesk

September 20, 9:42 AM

- Reuters

MRNA

Cyclo Therapeutics Announces Early Exercise Of Warrants By Board Members, Management And A Significant Shareholder Resulting In Cash Proceeds Of $2.4M

By Happy Mohamed

October 23, 8:18 AM

Issues New Warrants to this Investment Group for Possible Additional Funding of Up to $3.47 Million (if exercised) Cyclo Therapeutics, Inc. (NASDAQ:CYTH) ("Cyclo Therapeutics" or the

CYTH

Barclays Maintains Overweight on Amazon.com. Price adjusts to $195

Related Posts

Recent Report Shows That Rep. Virginia Foxx Sold Up to $100K Worth of Kellogg Stock

Ford Downgraded – Analyst Says Its Gen 2 EV Lags Compared To General Motors

EMA Talks Ongoing With Moderna About Application For Spikevax BA.4/BA.5 Adapted Bivalent Covid-19 Vaccine, Start Of Review Expected End Of Sept

Cyclo Therapeutics Announces Early Exercise Of Warrants By Board Members, Management And A Significant Shareholder Resulting In Cash Proceeds Of $2.4M